DE69838811D1 - Verfahren zur darstellung von abgestorbenen zellen in-vivo - Google Patents

Verfahren zur darstellung von abgestorbenen zellen in-vivo

Info

Publication number
DE69838811D1
DE69838811D1 DE69838811T DE69838811T DE69838811D1 DE 69838811 D1 DE69838811 D1 DE 69838811D1 DE 69838811 T DE69838811 T DE 69838811T DE 69838811 T DE69838811 T DE 69838811T DE 69838811 D1 DE69838811 D1 DE 69838811D1
Authority
DE
Germany
Prior art keywords
vivo
deadly
leaved
displaying
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69838811T
Other languages
English (en)
Other versions
DE69838811T2 (de
Inventor
Francis G Blankenberg
H W Strauss
Jonathan F Tait
Peter D Katsikis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Leland Stanford Junior University
Original Assignee
University of Washington
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Leland Stanford Junior University filed Critical University of Washington
Application granted granted Critical
Publication of DE69838811D1 publication Critical patent/DE69838811D1/de
Publication of DE69838811T2 publication Critical patent/DE69838811T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/40—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4057—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for generating radiation specially adapted for radiation diagnosis by using radiation sources located in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/42—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/425—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using detectors specially adapted to be used in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/42—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4258—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
DE69838811T 1997-04-30 1998-04-28 Verfahren zur darstellung von abgestorbenen zellen in-vivo Expired - Lifetime DE69838811T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4539997P 1997-04-30 1997-04-30
US45399P 1997-04-30
PCT/US1998/008769 WO1998048699A1 (en) 1997-04-30 1998-04-28 Method of imaging cell death in vivo

Publications (2)

Publication Number Publication Date
DE69838811D1 true DE69838811D1 (de) 2008-01-17
DE69838811T2 DE69838811T2 (de) 2008-10-30

Family

ID=21937648

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69838811T Expired - Lifetime DE69838811T2 (de) 1997-04-30 1998-04-28 Verfahren zur darstellung von abgestorbenen zellen in-vivo

Country Status (16)

Country Link
US (3) US6197278B1 (de)
EP (1) EP1017318B1 (de)
JP (1) JP4963748B2 (de)
KR (1) KR20010020443A (de)
CN (1) CN1265572A (de)
AT (1) ATE379990T1 (de)
AU (1) AU754577B2 (de)
CA (1) CA2288131A1 (de)
DE (1) DE69838811T2 (de)
ES (1) ES2398118T3 (de)
HU (1) HUP0001261A3 (de)
NZ (1) NZ500598A (de)
PL (1) PL336571A1 (de)
RU (1) RU2228765C2 (de)
TW (1) TW541184B (de)
WO (1) WO1998048699A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4963748B2 (ja) * 1997-04-30 2012-06-27 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー 細胞死をｉｎ ｖｉｖｏで撮像する方法
US7736651B1 (en) * 2000-11-24 2010-06-15 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
ATE276763T1 (de) 1998-07-13 2004-10-15 Univ Texas Verwendung von antikörper gegen aminophospholipide zur krebsbehandlung
AU750414B2 (en) * 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US6692724B1 (en) 1999-10-25 2004-02-17 Board Of Regents, The University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
CA2410906C (en) 2000-06-02 2012-10-02 Board Of Regents, The University Of Texas System Ethylenedicysteine (ec)-drug conjugates
WO2001097678A2 (en) * 2000-06-22 2001-12-27 Henry Ford Health System Imaging and targeting tumors using sickle cells
WO2002080754A2 (en) * 2001-04-03 2002-10-17 Theseus Imaging Corporation Methods for using annexin for detecting cell death in vivo and treating associated conditions
US6726895B2 (en) * 2001-04-03 2004-04-27 Board Of Trustees Of The Leland Stanford Junior University Method of imaging cell death in vivo
US20050013778A1 (en) * 2001-04-03 2005-01-20 Theseus Imaging Corporation Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death
EP1389090A2 (de) * 2001-04-26 2004-02-18 Board of Regents, The University of Texas System Diagnostische bildgebende zusammensetzungen, ihre syntheseverfahren und ihre verwendung
US20030202937A1 (en) * 2001-06-05 2003-10-30 Sabbadini Roger A. Minicell-based diagnostics
US20030152513A1 (en) * 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
US7261875B2 (en) 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
US20040042959A1 (en) * 2002-08-28 2004-03-04 Michael Montalto Imaging cell death in vivo using non-radionuclide contrast agents
CN1723042B (zh) * 2002-11-07 2010-12-01 得克萨斯大学体系董事会 乙二半胱氨酸(ec)-药物结合物、组合物及用于组织特异性疾病显像的方法
US20070031333A1 (en) * 2003-01-02 2007-02-08 Mease Ronnie C Novel F-18 labeled annexin V, synthesis thereof, and use thereof
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US7511016B2 (en) * 2004-07-07 2009-03-31 Mosamedix B.V. Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US9623129B2 (en) * 2005-09-26 2017-04-18 Snip Holdings, Inc. Methods and therapies for treating inflammatory conditions with exposed collagen
EP1946101A4 (de) * 2005-10-21 2011-08-10 Immunochemistry Technologies Llc In-vivo-apoptosenachweis
US7871623B2 (en) * 2005-12-21 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for imaging pain and stress in vivo
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2008093057A1 (en) * 2007-01-30 2008-08-07 Ge Healthcare Limited Tools for aiding in the diagnosis of neurodegenerative diseases
WO2008142590A2 (en) * 2007-05-16 2008-11-27 Koninklijke Philips Electronics N.V. Virtual pet detector and quasi-pixelated readout scheme for pet
US8055039B2 (en) * 2008-02-21 2011-11-08 General Electric Company System and method to obtain noise mitigated monochromatic representation for varying energy level
US8916570B2 (en) 2008-03-31 2014-12-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor agonists and antagonists
WO2009123881A1 (en) * 2008-03-31 2009-10-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Purine derivatives as a3 receptor- selective agonists
US9181253B2 (en) 2008-08-01 2015-11-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adenosine receptor agonists, partial agonists, and antagonists
EP2331542B1 (de) * 2008-08-01 2016-07-27 The United States of America, as Represented by The Secretary, Department of Health and Human Services Antagonisten und partielle agonisten des a3-adenosinrezeptors
ES2530228T3 (es) 2008-08-26 2015-02-27 Mosamedix B.V. Anexinas radiomarcadas
US8283167B2 (en) * 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
CN103582504B (zh) 2011-04-04 2016-04-27 艾迪国际研发有限公司 用于无针注射器的安全注射筒
US10286093B2 (en) * 2013-05-23 2019-05-14 Neurosn, Inc. Method of diagnosing and treating Alzheimer's disease
CN105669855B (zh) * 2016-02-04 2020-02-11 江苏省原子医学研究所 一种18F快速标记Cys-Annexin V的方法及其应用
RU2622983C1 (ru) * 2016-07-25 2017-06-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ интраоперационной визуализации ишемически-реперфузионного повреждения миокарда
WO2019169241A1 (en) * 2018-03-02 2019-09-06 Serene, Llc Methods of treating and imaging ungulate laminitis
JP2024022034A (ja) * 2022-08-05 2024-02-16 浜松ホトニクス株式会社 プログラムされた細胞死を起こした細胞の領域を決定する方法、決定部を備える装置及び決定ステップを含む情報処理プログラム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671256A (en) * 1984-05-25 1987-06-09 Lemelson Jerome H Medical scanning, monitoring and treatment system and method
US5627036A (en) 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5552525A (en) 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
CA2086437A1 (en) 1991-05-09 1992-11-10 Jonathan Tait Phospholipid-targeted thrombolytic agents
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
US5519221A (en) 1992-01-22 1996-05-21 Ansel M. Schwartz Dedicated apparatus and method for emission mammography
DK0627940T3 (da) 1992-03-05 2003-09-01 Univ Texas Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5776427A (en) 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
GB9223168D0 (en) 1992-11-05 1992-12-16 Johnson Matthey Plc Improvements in molecule labelling
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US5834196A (en) 1994-04-11 1998-11-10 Nexins Research B.V. Method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
JPH10504534A (ja) 1994-06-16 1998-05-06 ネオルクス コーポレイション 放射性標識アネキシン−ガラクトース結合体
WO1996017618A1 (en) 1994-12-07 1996-06-13 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
JP4963748B2 (ja) * 1997-04-30 2012-06-27 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー 細胞死をｉｎ ｖｉｖｏで撮像する方法
ATE276763T1 (de) 1998-07-13 2004-10-15 Univ Texas Verwendung von antikörper gegen aminophospholipide zur krebsbehandlung
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
AU750414B2 (en) 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

Also Published As

Publication number Publication date
DE69838811T2 (de) 2008-10-30
RU2228765C2 (ru) 2004-05-20
US20080138279A1 (en) 2008-06-12
CN1265572A (zh) 2000-09-06
US6197278B1 (en) 2001-03-06
KR20010020443A (ko) 2001-03-15
TW541184B (en) 2003-07-11
HUP0001261A3 (en) 2001-11-28
EP1017318A4 (de) 2003-04-23
AU754577B2 (en) 2002-11-21
JP4963748B2 (ja) 2012-06-27
HUP0001261A2 (hu) 2000-08-28
AU7271498A (en) 1998-11-24
ATE379990T1 (de) 2007-12-15
US20070243133A1 (en) 2007-10-18
JP2002500757A (ja) 2002-01-08
NZ500598A (en) 2001-09-28
PL336571A1 (en) 2000-07-03
WO1998048699A1 (en) 1998-11-05
US7357915B2 (en) 2008-04-15
CA2288131A1 (en) 1998-11-05
EP1017318A1 (de) 2000-07-12
EP1017318B1 (de) 2007-12-05
ES2398118T3 (es) 2013-03-13
US7666389B2 (en) 2010-02-23

Similar Documents

Publication Publication Date Title
DE69838811D1 (de) Verfahren zur darstellung von abgestorbenen zellen in-vivo
DE69901937T2 (de) Verfahren zur herstellung von elektroden
DE69813183D1 (de) Verfahren zur elektrolytischen herstellung von metallen
DE69925052D1 (de) Verfahren zur Herstellung von wasserstoffreichem Gas
DE69713022T2 (de) Verfahren zur Herstellung von Unterkleidung
DE59814185D1 (de) Verfahren zur herstellung von verzweigten polycarbonaten
DE69613333D1 (de) Verfahren zur Herstellung von Kathodenmischungen für Batterien
DE69909003D1 (de) Verfahren zur Herstellung von Polyamiden
DE69802534D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE69932142D1 (de) Verfahren zur herstellung von nickelpulver
DE69933207D1 (de) Verbessertes verfahren zur herstellung von makroliden
DE69533773D1 (de) Verfahren zur Herstellung von Isolationsgraben
DE69903698D1 (de) Verfahren zur Herstellung von Acrylsäure
DE59907055D1 (de) Verfahren zur herstellung von tetrachlorkohlenstoffarmen phosgen
DE69935509D1 (de) Verfahren zur herstellung von durchscheinenden zahnersätzen
DE69926449D1 (de) Verfahren zur herstellung von pulvrigem nickel
DE69727866D1 (de) Verfahren zur Herstellung von Animationen
DE69928463D1 (de) Verfahren zur Herstellung von Stahlkomponenten
ATA219297A (de) Enzymatisches verfahren zur herstellung von (s)-cyanhydrinen
DE60138164D1 (de) Verfahren zur elektrochemischen Bearbeitung von Kanälen
DE60006144D1 (de) Verfahren für die elektrochemische herstellung von ni(0) phosphit und diphosphitkomplexen
ATE204023T1 (de) Enzymatische verfahren zur herstellung von (s)- cyanhydrinen
DE59802293D1 (de) Verfahren zur Herstellung von Metall-Kunststoff-Verbundelementen
DE69832063D1 (de) Ein verbessertes Verfahren zur Herstellung von stabilen wässrigen Urethandispersionen
DE69921634D1 (de) Verfahren zur Herstellung von ölige Konzentrate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition